help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-114-2-541
Endocrinology Vol. 114, No. 2 541-544
Copyright © 1984 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ZENSER, T. V.
Right arrow Articles by DAVIS, B. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ZENSER, T. V.
Right arrow Articles by DAVIS, B. B.

Independent Effects of Bradykinin on Adenosine 3',5'-Monophosphate and Prostaglandin E2 Metabolism by Rabbit Renal Medulla*

TERRY V. ZENSER, NEVILLE S. RAPP, LESLIE A. SPRY and BERNARD B. DAVIS

Veterans Administration Medical Center, Geriatric Research, Education, and Clinical Center St. Louis, Missouri 63125
Departments of Medicine and Biochemistry, St. Louis University School of Medicine St. Louis, Missouri 63106

Address all correspondence and requests for reprints to: Terry V. Zenser, Ph.D., Veterans Administration Medical Center (111G-JB), St. Louis, Missouri 63125.

Abstract

Bradykinin-stimulated increases in renal prostaglandin (PG) synthesis are thought to result in subsequent increases in cAMP content. This study assesses the relationship between bradykinin-stimulated increases in PGE2 and cAMP syntheses in renal inner medullary slices. Bradykinin-mediated increases in cAMP (2 min) preceded those in PGE2 (5 min) synthesis. Forskolin, an activator of adenylate cyclase, increased cAMP, while 2',5'-dideoxyadenosine, an adenylate cyclase inhibitor, reduced cAMP. However, neither agent altered bradykinin-stimulated PGE2 synthesis. Aspirin decreased basal and abolished bradykinin-stimulated PGE2 production, but did not alter bradykinin-induced increases in cAMP content. Maximal stimulatory concentrations of 1-methyl-3-isobutylxanthine, a cyclic nucleotide phosphodiesterase inhibitor, and bradykinin were additive in their capacity to increase inner medullary cAMP content. These results suggest that l-methyl-3-isobutylxanthine and bradykinin increase cAMP by separate mechanisms and that bradykinin increases inner medullary cAMP by a direct effect on the production of that cyclic nucleotide. Bradykininmediated increases in cAMP and PGE2 syntheses by renal medullary slices are independent effects of this renally acting hormone. (Endocrinology 114: 541, 1984)

Footnotes

* This work was supported by the V.A. and the American Cancer Society, Missouri Division.

Received January 28, 1983.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society